Increasing evidence shows that TGF-β not only suppresses CD8+ effector T-cell activity but also drives the conversion of CD4+ helper T cells into regulatory T cells (Tregs), collectively dampening anti-tumor immune responses [201]. Here, TGFB1 is linked to neoplasm.